WallStreetZenWallStreetZen

NASDAQ: AVGR
Avinger Inc Stock Forecast, Predictions & Price Target

Analyst price target for AVGR

Based on 1 analyst offering 12 month price targets for Avinger Inc.
Min Forecast
$5.00+27.23%
Avg Forecast
$5.00+27.23%
Max Forecast
$5.00+27.23%

Should I buy or sell AVGR stock?

Based on 1 analyst offering ratings for Avinger Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their AVGR stock forecasts and price targets.

AVGR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-21

1 of 1

Forecast return on equity

Is AVGR forecast to generate an efficient return?
Insufficient data to display

Forecast return on assets

Is AVGR forecast to generate an efficient return on assets?

AVGR revenue forecast

What is AVGR's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$10.5M+37.22%
Avg 2 year Forecast
$13.9M+82.04%
Avg 3 year Forecast
$17.8M+132.62%
AVGR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AVGR revenue growth forecast

How is AVGR forecast to perform vs Medical Instruments & Supplies companies and vs the US market?
Company
32.5%
Industry
8.57%
Market
9.92%
AVGR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AVGR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AVGR vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
AVGR$3.93$5.00+27.23%Buy
POAI$1.66N/AN/A
STSS$0.29N/AN/A
LUCY$0.24$1.00+314.94%Strong Buy
GCTK$0.46N/AN/A

Avinger Stock Forecast FAQ

Is Avinger Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: AVGR) stock is to Buy AVGR stock.

Out of 1 analyst, 0 (0%) are recommending AVGR as a Strong Buy, 1 (100%) are recommending AVGR as a Buy, 0 (0%) are recommending AVGR as a Hold, 0 (0%) are recommending AVGR as a Sell, and 0 (0%) are recommending AVGR as a Strong Sell.

If you're new to stock investing, here's how to buy Avinger stock.

What is AVGR's revenue growth forecast for 2024-2026?

(NASDAQ: AVGR) Avinger's forecast annual revenue growth rate of 32.5% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.57%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.92%.

Avinger's revenue in 2024 is $7,652,000.On average, 1 Wall Street analysts forecast AVGR's revenue for 2024 to be $17,873,373, with the lowest AVGR revenue forecast at $17,873,373, and the highest AVGR revenue forecast at $17,873,373. On average, 1 Wall Street analysts forecast AVGR's revenue for 2025 to be $23,712,008, with the lowest AVGR revenue forecast at $23,712,008, and the highest AVGR revenue forecast at $23,712,008.

In 2026, AVGR is forecast to generate $30,299,623 in revenue, with the lowest revenue forecast at $30,299,623 and the highest revenue forecast at $30,299,623.

What is AVGR's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: AVGR) forecast ROA is N/A, which is lower than the forecast US Medical Instruments & Supplies industry average of N/A.

What is AVGR's Price Target?

According to 1 Wall Street analyst that have issued a 1 year AVGR price target, the average AVGR price target is $5.00, with the highest AVGR stock price forecast at $5.00 and the lowest AVGR stock price forecast at $5.00.

The Wall Street analyst predicted that Avinger's share price could reach $5.00 by Mar 21, 2025. The average Avinger stock price prediction forecasts a potential upside of 27.23% from the current AVGR share price of $3.93.

What is AVGR's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: AVGR) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.